Pharmaceutical Executive: May 2025

View the Pharmaceutical Executive May 2025 issue in an interactive format.

Tapping into the reader experience, our new comprehensive survey uncovers valuable input for navigating the changing tides facing pharma decision-makers.

Our exclusive poll captures today's top trends and perspectives—shaped by those pharma decision-makers impacted the most.

Reshema Kemps-Polanco, executive VP and chief commercial officer, Novartis US, and the 2025 Healthcare Businesswomen’s Association Woman of the Year, uses the lessons she learned from her family to bring out the best in her teams.

Meeting the growing need and demand for fast information to make optimal and timely treatment decisions.

The latest Q&A installment in Pharm Exec's earned media series details key strategies for leveraging breaking news at industry trade shows, including the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting.

A well-defined scientific and strategic approach is critical for buyers in this dealmaking setting.

Identifying the priorities that translate to strong business outcomes—and separating the top performers from the average brands.

Navigating technology and regulatory shifts in pharma revenue management.

Five steps for organizations in bringing enterprise-level strategies to life.

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and profitability.

The argument for weighing clinical points more heavily in the access equation.